These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 33860589)
1. Clinical Efficacy of Ruxolitinib Monotherapy and Haploidentical Hematopoeitic Stem Cell Transplantation in a Child with Philadelphia Chromosome-like Relapsed/Refractory acute lymphoblastic leukemia. Bayram N; Yaman Y; Özdilli K; Telhan L; Nepesov S; Bilgen H; Elli M; Behar SS; Anak S Pediatr Transplant; 2021 Jun; 25(4):e14024. PubMed ID: 33860589 [TBL] [Abstract][Full Text] [Related]
2. Haploidentical hematopoietic stem cell transplantation for pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia in the imatinib era. Chen H; Liu KY; Xu LP; Chen YH; Zhang XH; Wang Y; Qin YZ; Liu YR; Lai YY; Huang XJ Leuk Res; 2017 Aug; 59():136-141. PubMed ID: 28654842 [TBL] [Abstract][Full Text] [Related]
3. How is the Ph-like signature being incorporated into ALL therapy? Maese L; Tasian SK; Raetz EA Best Pract Res Clin Haematol; 2017 Sep; 30(3):222-228. PubMed ID: 29050695 [TBL] [Abstract][Full Text] [Related]
4. Developmental origins and impact of BCR-ABL1 fusion and IKZF1 deletions in monozygotic twins with Ph+ acute lymphoblastic leukemia. Cazzaniga G; van Delft FW; Lo Nigro L; Ford AM; Score J; Iacobucci I; Mirabile E; Taj M; Colman SM; Biondi A; Greaves M Blood; 2011 Nov; 118(20):5559-64. PubMed ID: 21960589 [TBL] [Abstract][Full Text] [Related]
5. Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China. Gao L; Zhang C; Gao L; Liu Y; Su Y; Wang S; Li B; Yang T; Yuan Z; Zhang X J Hematol Oncol; 2015 Jul; 8():90. PubMed ID: 26208715 [TBL] [Abstract][Full Text] [Related]
6. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia. Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612 [TBL] [Abstract][Full Text] [Related]
7. Sustained remission after ruxolitinib and chimeric antigen receptor T-cell therapy bridged to a second allogeneic hematopoietic stem cell transplantation for relapsed Philadelphia chromosome-like B-cell precursor acute lymphoblastic leukemia with novel NPHP3-JAK2 fusion. Chen X; Yuan L; Zhou J; Wang F; Zhang Y; Ma X; Cao P; Fang J; Chen J; Zhou X; Wu Q; Liu M; Liu H Genes Chromosomes Cancer; 2022 Jan; 61(1):55-58. PubMed ID: 34418218 [No Abstract] [Full Text] [Related]
8. Efficacy of ruxolitinib in acute lymphoblastic leukemia: A systematic review. Kołodrubiec J; Kozłowska M; Irga-Jaworska N; Sędek Ł; Pastorczak A; Trelińska J; Młynarski W Leuk Res; 2022 Oct; 121():106925. PubMed ID: 35939887 [TBL] [Abstract][Full Text] [Related]
10. T-cell-rich HLA-haploidentical hematopoietic stem cell transplantation for relapsed/refractory pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia without posttransplant tyrosine kinase inhibitor therapy. Sano H; Mochizuki K; Akaihata M; Kobayashi S; Ohto H; Kikuta A Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781393 [TBL] [Abstract][Full Text] [Related]
11. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041 [TBL] [Abstract][Full Text] [Related]
12. The biology of Philadelphia chromosome-like ALL. Roberts KG Best Pract Res Clin Haematol; 2017 Sep; 30(3):212-221. PubMed ID: 29050694 [TBL] [Abstract][Full Text] [Related]
13. Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia. Sutton R; Shaw PJ; Venn NC; Law T; Dissanayake A; Kilo T; Haber M; Norris MD; Fraser C; Alvaro F; Revesz T; Trahair TN; Dalla-Pozza L; Marshall GM; O'Brien TA Br J Haematol; 2015 Feb; 168(3):395-404. PubMed ID: 25312094 [TBL] [Abstract][Full Text] [Related]
14. Decitabine for relapsed acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Cui JK; Xiao Y; You Y; Shi W; Li Q; Luo Y; Jiang L; Zhong ZD J Huazhong Univ Sci Technolog Med Sci; 2017 Oct; 37(5):693-698. PubMed ID: 29058281 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic Hematopoietic Stem Cell Transplantation, Especially Haploidentical, May Improve Long-Term Survival for High-Risk Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Tyrosine Kinase Inhibitor Era. Xue YJ; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ Biol Blood Marrow Transplant; 2019 Aug; 25(8):1611-1620. PubMed ID: 30537550 [TBL] [Abstract][Full Text] [Related]
16. Imatinib use immediately before stem cell transplantation in children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Results from Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) Study Ph(+) ALL04. Manabe A; Kawasaki H; Shimada H; Kato I; Kodama Y; Sato A; Matsumoto K; Kato K; Yabe H; Kudo K; Kato M; Saito T; Saito AM; Tsurusawa M; Horibe K Cancer Med; 2015 May; 4(5):682-9. PubMed ID: 25641907 [TBL] [Abstract][Full Text] [Related]
17. Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia. Jeha S; Coustan-Smith E; Pei D; Sandlund JT; Rubnitz JE; Howard SC; Inaba H; Bhojwani D; Metzger ML; Cheng C; Choi JK; Jacobsen J; Shurtleff SA; Raimondi S; Ribeiro RC; Pui CH; Campana D Cancer; 2014 May; 120(10):1514-9. PubMed ID: 24501014 [TBL] [Abstract][Full Text] [Related]
18. Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study. Zhao H; Wei J; Wei G; Luo Y; Shi J; Cui Q; Zhao M; Liang A; Zhang Q; Yang J; Li X; Chen J; Song X; Jing H; Li Y; Hao S; Wu W; Tan Y; Yu J; Zhao Y; Lai X; Yin ETS; Wei Y; Li P; Huang J; Wang T; Blaise D; Xiao L; Chang AH; Nagler A; Mohty M; Huang H; Hu Y J Hematol Oncol; 2020 May; 13(1):42. PubMed ID: 32366260 [TBL] [Abstract][Full Text] [Related]
19. IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report. Martinelli G; Iacobucci I; Storlazzi CT; Vignetti M; Paoloni F; Cilloni D; Soverini S; Vitale A; Chiaretti S; Cimino G; Papayannidis C; Paolini S; Elia L; Fazi P; Meloni G; Amadori S; Saglio G; Pane F; Baccarani M; Foà R J Clin Oncol; 2009 Nov; 27(31):5202-7. PubMed ID: 19770381 [TBL] [Abstract][Full Text] [Related]
20. Haploidentical hematopoietic stem cell transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia: no difference in the high- and low-risk groups. Mo XD; Xu LP; Zhang XH; Liu DH; Wang Y; Chen H; Yan CH; Chen YH; Han W; Wang FR; Wang JZ; Liu KY; Huang XJ Int J Cancer; 2015 Apr; 136(7):1697-707. PubMed ID: 25138425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]